Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Shenzhen Chipscreen Biosciences Ltd.
DescriptionJanus kinase-3 (JAK-3) inhibitor
Molecular Target Janus kinase-3 (JAK-3)
Mechanism of ActionJanus kinase-3 (JAK-3) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today